Evidence map›Paper›PMID 40424522›Full record

SynthesisNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2025

Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis.

Denise M J Veltkamp, Cindy P Porras, Christina M Gant, Wouter M Tiel Groenestege, Maarten B Kok, Marianne C Verhaar, Wouter W van Solinge, Saskia Haitjema, Robin W M Vernooij

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Macrophage-Fibroblast Crosstalk in Kidney Injury: A Narrative Review.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Research progress on biomarkers for acute kidney injury in children.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Denise M J VeltkampDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0001-9914-7827
Cindy P PorrasDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0001-7692-9164
Christina M GantDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Wouter M Tiel GroenestegeCentral Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Maarten B KokSaltro BV, Unilabs Netherlands, Utrecht, the Netherlands.
Marianne C VerhaarDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Wouter W van SolingeCentral Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Saskia HaitjemaCentral Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0001-5465-4868
Robin W M VernooijDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0001-5734-4566

Funding

Top Sector Life Sciences & Health
6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is associated with increased risks of incidence or progression of chronic kidney disease (CKD), kidney failure (KF), or major adverse kidney events (MAKE), however, it remains unclear which individuals have higher risks. Hence, we systematically reviewed the literature to explore differences in kidney dysfunction risks between AKI stages, AKI durations, and clinical settings.

methodsWe performed a systematic search in PubMed and Embase to identify studies that examined at least one outcome of interest in individuals with AKI versus without AKI, with a minimum follow-up of one year. Hazard/odds ratios (HR/OR) were pooled using random effects models. Heterogeneity across patient and disease characteristics was examined using subgroup and meta-regression analyses.

resultsWe searched 70 studies, encompassing 1 838 668 individuals, including 165 715 with AKI. All studies were of moderate to high quality. Individuals with AKI had higher risks of CKD incidence [AKI 25.8%/no AKI 8.7%; HR 2.36 [95% confidence interval (CI) 1.77-2.94)]], CKD progression [AKI 43.1%/no AKI 35.6%; HR 1.83 (95%CI 1.26-2.40)], KF [AKI 2.9%/no AKI 0.5%; HR 2.64 (95%CI 2.03-3.25)], and MAKE [AKI 59.0%/no AKI 32.7%; OR 2.77 (95%CI 2.01-3.53)]. The pooled effect estimates for CKD incidence after AKI lasting <3 days remained significant [OR 2.37 (95%CI 1.68-3.07)], even in individuals with AKI stage 1 only [HR 1.49 (95%CI 1.44-1.55)]. Diabetes mellitus, hypertension, requiring acute dialysis, cardiovascular surgery, or coronary artery disease were associated with higher CKD incidence or progression risks.

conclusionsRisks for kidney dysfunction were higher for all individuals with AKI. Risk estimates were heterogeneous between patient subgroups, based on AKI stage, AKI duration, and clinical setting, yet even individuals with the lowest stage or shortest duration of AKI remained at higher risk for CKD incidence or progression. This highlights the need to develop tailored follow-up strategies to recognize kidney function decline post-AKI and initiate kidney protective measures in a timely fashion.

Indexed as

Acute Kidney InjuryRenal Insufficiency, ChronicDisease ProgressionHumansIncidencePrognosisRisk Factorsacute kidney injurychronic kidney diseasekidney failurelong-term outcomesmajor adverse kidney event

Identifiers

PMID40424522
PMCPMC12559794

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.